This is a premixed vial of CJC-1295 without DAC (also called Mod GRF 1-29) and ipamorelin, usually 5 mg of each (10 mg total), and it's the most common growth hormone peptide blend. It doesn't contain growth hormone. Instead, it tells your pituitary, a small gland under your brain, to release more of its own.
How it works
Your body uses two signals for growth hormone: one says release, and the other makes each release bigger. CJC-1295 copies the first and ipamorelin copies the second, so using both tends to give a bigger burst than either alone. People like ipamorelin because in animal studies it raised growth hormone without much rise in two other hormones, cortisol and prolactin.
What people use it for
Sleep quality
Recovery from training
Body shape (less fat, more lean muscle)
Skin and general wellbeing
The evidence
Some human studies
There are small human studies of each part, but none of this blend. The best-known human CJC-1295 studies used a different, week-long version (with DAC), the short-acting version in this blend has very little human data, and ipamorelin was tested in people only for gut recovery after surgery, not fitness or anti-aging. No trial has shown this blend improves body fat, muscle or sleep in healthy adults.
Bedtime, on an empty stomach (at least 2 hours after food)
Cycle
8–12 weeks, often 5 days on and 2 days off, then a break of similar length
Route
Subcutaneous injection
Why: Your biggest natural growth hormone burst happens early in sleep, so a bedtime dose adds to it. Food, especially carbs and fat, dulls the release, so people take it on an empty stomach. Both parts wear off fast, so the effect fits one burst. Example: add 2 mL of bacteriostatic water to a 10 mg vial. That makes 5 mg/mL of blend. A 200 µg dose (100 µg of each) is 0.04 mL, or 4 units on a U-100 insulin syringe.
Low/starter
Reported
Dose
100–200 µg of blend (50–100 µg of each)
How often
Once a day
When
Bedtime, empty stomach
Cycle
First 1–2 weeks
Route
Subcutaneous injection
Why: Starting low lets you watch for water retention, tingling hands or flushing before you go higher. With the 2 mL mix above, 100 µg of blend is 0.02 mL, or 2 units.
Start at the low end, and change one thing at a time. If you take medication or have a health condition, check with a doctor first.
Mostly no. The main human studies used CJC-1295 with DAC, which lasts about a week. This blend uses the no-DAC version, which lasts minutes and gives a short burst instead.
Why one vial instead of two?
Fewer shots and less mixing. The catch is the ratio is fixed, so you can't raise ipamorelin without raising CJC-1295 too.
Will it work like taking growth hormone?
No. It only boosts your own release, which is much smaller and still controlled by your body. Any effects build slowly over weeks.
Sources
Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. PubMed 16352683
Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-7. PubMed 17018654
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61. PubMed 9849822
Dominikowski A, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026;17:1822475. PubMed 42395176